{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:40:20Z","timestamp":1789609220781,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.leukres.2017.03.008","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T14:46:16Z","timestamp":1490193976000},"page":"14-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review"],"prefix":"10.1016","volume":"58","author":[{"given":"Prajwal","family":"Boddu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Falchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Hosing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Newberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithviraj","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.03.008_bib0005","unstructured":"I. Bakul, M. Dalai, FRCPC, FCAP, Albert M. Nyokong, BSc, RT, Hyperthrombocytosis: a Clinicohematological Study Laboratory medicine, 23 (No. 12) (1992) p. 811\u2013814."},{"issue":"8279","key":"10.1016\/j.leukres.2017.03.008_bib0010","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(82)92021-9","article-title":"Essential thrombocythaemia","volume":"1","author":"Preston","year":"1982","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.leukres.2017.03.008_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1054\/blre.2001.0162","article-title":"Thrombocytosis and thrombocythemia","volume":"15","author":"Schafer","year":"2001","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0889-8588(18)30511-2","article-title":"Thrombocytosis and thrombocythemia","volume":"4","author":"Mitus","year":"1990","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"12","key":"10.1016\/j.leukres.2017.03.008_bib0025","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/1097-0142(19880615)61:12<2487::AID-CNCR2820611217>3.0.CO;2-T","article-title":"Essential thrombocythemia: clinical characteristics and course of 61 cases","volume":"61","author":"Hehlmann","year":"1988","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000206719","article-title":"Thrombocytosis and microthrombocytosis: a clinical evaluation of 372 cases","volume":"70","author":"Robbins","year":"1983","journal-title":"Acta Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2141.1989.tb04288.x","article-title":"Primary thrombocythaemia: diagnostic criteria and a simple scoring system for positive diagnosis","volume":"71","author":"Dudley","year":"1989","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.leukres.2017.03.008_bib0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2014-05-578435","article-title":"Clinical effect of driver mutations of JAK2: CALR, or MPL in primary myelofibrosis","volume":"124","author":"Rumi","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2017.03.008_bib0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/leu.2011.258","article-title":"Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria","volume":"26","author":"Finazzi","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.03.008_bib0050","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.14553","article-title":"Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome","author":"Sora","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/adc.68.1.88","article-title":"Secondary thrombocytosis","volume":"68","author":"Vora","year":"1993","journal-title":"Arch. Dis. Child"},{"issue":"6","key":"10.1016\/j.leukres.2017.03.008_bib0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.1991.tb00383.x","article-title":"Thrombocytosis in adults: analysis of 777 patients","volume":"229","author":"Santhosh-Kumar","year":"1991","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.leukres.2017.03.008_bib0065","series-title":"Wintrobe's Clinical Hematology","first-page":"1128","author":"Greer","year":"1981"},{"issue":"2","key":"10.1016\/j.leukres.2017.03.008_bib0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1537-2995.1979.19279160283.x","article-title":"Therapeutic plateletpheresis in thombocythemia","volume":"19","author":"Panlilio","year":"1979","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.leukres.2017.03.008_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.2830190208","article-title":"Evidence for rapid mobilization of platelets from the spleen during intensive plateletpheresis","volume":"19","author":"Lee","year":"1985","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2017.03.008_bib0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archsurg.1978.01370180055006","article-title":"Postsplenectomy thrombocytosis: its association with mesenteric, portal, and\/or renal vein thrombosis in patients with myeloproliferative disorders","volume":"113","author":"Gordon","year":"1978","journal-title":"Arch. Surg."},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood.V36.1.61.61","article-title":"Hemorrhagic thrombocythemia; control of postsplenectomy thrombocytosis with melphalan","volume":"36","author":"Bensinger","year":"1970","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4065\/76.1.22","article-title":"A long-term retrospective study of young women with essential thrombocythemia","volume":"76","author":"Tefferi","year":"2001","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.leukres.2017.03.008_bib0095","first-page":"537","article-title":"Essential thrombocythemia: a retrospective study on the clinical course of 100 patients","volume":"75","author":"Chistolini","year":"1990","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2017.03.008_bib0100","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/bjh.14443","article-title":"Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?","volume":"176","author":"Falchi","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.leukres.2017.03.008_bib0105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia","volume":"123","year":"1995","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","article-title":"Clinical course of essential thrombocythemia in 147 cases","volume":"66","author":"Fenaux","year":"1990","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.leukres.2017.03.008_bib0115","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y","article-title":"Essential thrombocythemias: clinical evolutionary and biological data","volume":"58","author":"Bellucci","year":"1986","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2017.03.008_bib0120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand's disease in the myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1986.tb07497.x","article-title":"Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis","volume":"63","author":"Fabris","year":"1986","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.leukres.2017.03.008_bib0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ajcp\/91.6.647","article-title":"Platelet function and structure in myeloproliferative disease: myelodysplastic syndrome, and secondary thrombocytosis","volume":"91","author":"Raman","year":"1989","journal-title":"Am. J. Clin. Pathol."},{"issue":"11","key":"10.1016\/j.leukres.2017.03.008_bib0135","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.2015.8515","article-title":"Thrombocytosis","volume":"314","author":"Schafer","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.leukres.2017.03.008_bib0140","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet","volume":"29","author":"Barbui","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 5","key":"10.1016\/j.leukres.2017.03.008_bib0145","doi-asserted-by":"crossref","first-page":"v85","DOI":"10.1093\/annonc\/mdv203","article-title":"Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Vannucchi","year":"2015","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.leukres.2017.03.008_bib0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3949\/ccjm.73.8.767","article-title":"Thrombocytosis: when is an incidental finding serious?","volume":"73","author":"Schafer","year":"2006","journal-title":"Cleve. Clin. J. Med."},{"issue":"5","key":"10.1016\/j.leukres.2017.03.008_bib0155","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.leukres.2004.10.002","article-title":"Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders","volume":"29","author":"Fruchtman","year":"2005","journal-title":"Leuk. Res."},{"issue":"17","key":"10.1016\/j.leukres.2017.03.008_bib0160","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.leukres.2017.03.008_bib0165","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11899-016-0335-0","article-title":"The use of anagrelide in myeloproliferative neoplasms: with focus on essential thrombocythemia","volume":"11","author":"Birgegard","year":"2016","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"10","key":"10.1016\/j.leukres.2017.03.008_bib0170","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2012-07-443770","article-title":"Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial","volume":"121","author":"Gisslinger","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0175","first-page":"51","article-title":"Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative disorders","volume":"34","author":"Petitt","year":"1997","journal-title":"Semin. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2017.03.008_bib0180","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3324\/haematol.2012.083097","article-title":"Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study","volume":"99","author":"Gugliotta","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0185","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1537-2995.1979.19379204219.x","article-title":"Long-term plateletpheresis in the management of primary thrombocytosis","volume":"19","author":"Goldfinger","year":"1979","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.leukres.2017.03.008_bib0190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1774-9987.2004.00187.x","article-title":"Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia","volume":"8","author":"Thakral","year":"2004","journal-title":"Ther. Apher. Dial."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0195","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-Evidence-based approach from the writing committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J. Clin. Apher."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0200","first-page":"133","article-title":"Blue toe syndrome in a patient with essential thrombocythemia: favorable response to plateletpheresis (author's transl)","volume":"79","author":"Gonzalez","year":"1982","journal-title":"Med. Clin. (Barc)"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0205","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.athoracsur.2011.02.050","article-title":"Thrombocytapheresis: managing essential thrombocythemia in a surgical patient","volume":"92","author":"Das","year":"2011","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.leukres.2017.03.008_bib0210","first-page":"296","article-title":"Plateletpheresis as a preventive measure to complications of asymptomatic cases of idiopathic thrombocythemia","volume":"67","author":"Larison","year":"1978","journal-title":"J. Med. Assoc. Ga."},{"issue":"9","key":"10.1016\/j.leukres.2017.03.008_bib0215","first-page":"851","article-title":"Chronic subdural hematoma associated with primary thrombocythemia; report of an operated case: using plateletpheresis","volume":"19","author":"Sugawara","year":"1991","journal-title":"No Shinkei Geka"},{"issue":"5","key":"10.1016\/j.leukres.2017.03.008_bib0220","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajem.2007.09.025","article-title":"Management of femoral fracture in a patient with essential thrombocythemia treated with plateletpheresis and intramedullary rod fixation, followed by hydroxyurea: a case report","volume":"26","author":"Edlich","year":"2008","journal-title":"Am. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.leukres.2017.03.008_bib0225","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jca.20101","article-title":"Periodic plateletpheresis during pregnancy in a high-risk patient with essential thrombocythemia","volume":"21","author":"Yamaguchi","year":"2006","journal-title":"J. Clin. Apher."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0230","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08122.x","article-title":"Guideline for investigation and management of adults and children presenting with a thrombocytosis","volume":"149","author":"Harrison","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2017.03.008_bib0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/10428199609074371","article-title":"Interferon-alpha in the treatment of essential thrombocythemia","volume":"22","author":"Lengfelder","year":"1996","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.leukres.2017.03.008_bib0240","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.3324\/haematol.2015.139691","article-title":"Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series","volume":"101","author":"Beauverd","year":"2016","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2017.03.008_bib0245","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00006254-199704000-00021","article-title":"Essential thrombocythemia during pregnancy","volume":"52","author":"Eliyahu","year":"1997","journal-title":"Obstet. Gynecol. Surv."},{"issue":"2","key":"10.1016\/j.leukres.2017.03.008_bib0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.transci.2007.07.004","article-title":"Change of coagulation parameters after double plateletpheresis","volume":"37","author":"Yilmaz","year":"2007","journal-title":"Transfus. Apher. Sci."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0255","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.transci.2013.08.004","article-title":"Effects of plateletpheresis on blood coagulation parameters in healthy donors at National Blood Centre, Kuala Lumpur, Malaysia","volume":"49","author":"Siti Nadiah","year":"2013","journal-title":"Transfus. Apher. Sci."},{"issue":"7","key":"10.1016\/j.leukres.2017.03.008_bib0260","first-page":"1207","article-title":"Von Willebrand factor multimer structure is neither acutely nor chronically affected by plateletpheresis","volume":"60","author":"Weiss","year":"2014","journal-title":"Clin. Lab."},{"issue":"5","key":"10.1016\/j.leukres.2017.03.008_bib0265","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1537-2995.1980.20581034507.x","article-title":"Improvement of platelet function following plateletpheresis in patients with myeloproliferative diseases","volume":"20","author":"Orlin","year":"1980","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0270","first-page":"39","article-title":"The morphological properties of the blood thrombocytes in bronchial asthma patients before and after thrombocytapheresis","volume":"67","author":"Tatarskii","year":"1995","journal-title":"Ter Arkh"},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0275","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0955-3886(00)00084-9","article-title":"Single automated donor plateletpheresis increases the plasma level of proinflammatory cytokine tumor necrosis factor-alpha which does not associate with endothelial release markers von Willebrand factor and fibronectin","volume":"23","author":"Karadogan","year":"2000","journal-title":"Transfus. Sci."},{"issue":"2","key":"10.1016\/j.leukres.2017.03.008_bib0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1423-0410.2000.7820101.x","article-title":"Extracorporeal plateletpheresis induces the interaction of activated platelets with white blood cells","volume":"78","author":"Gutensohn","year":"2000","journal-title":"Vox Sang."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0285","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1537-2995.2005.04269.x","article-title":"Plateletpheresis does not cause long-standing platelet-derived growth factor release into the donor blood","volume":"45","author":"Zimmermann","year":"2005","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.leukres.2017.03.008_bib0290","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/trf.13419","article-title":"Central retinal vein occlusion after plateletpheresis","volume":"56","author":"Roddy","year":"2016","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.leukres.2017.03.008_bib0295","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2141.2002.03275.x","article-title":"Axillary vein thrombosis in a healthy donor following platelet apheresis","volume":"116","author":"Jones","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2017.03.008_bib0300","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1537-2995.1998.tb03478.x","article-title":"Platelet activation and interval between plateletpheresis","volume":"38","author":"Sanz","year":"1998","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.leukres.2017.03.008_bib0305","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1537-2995.1999.39080889.x","article-title":"The influence of automated plateletpheresis on systemic levels of hematopoietic growth factors","volume":"39","author":"Weisbach","year":"1999","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.leukres.2017.03.008_bib0310","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1537-2995.1999.39499235679.x","article-title":"Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels","volume":"39","author":"Schoffski","year":"1999","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0315","first-page":"3","article-title":"Intermittent-flow versus continuous-flow mononuclear cell apheresis","volume":"24","author":"Storek","year":"1991","journal-title":"Haematologia (Budap)"},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0320","first-page":"389","article-title":"Thrombocytopheresis: a rapid and effective approach to symptomatic thrombocytosis","volume":"68","author":"Colman","year":"1966","journal-title":"J. Lab. Clin. Med."},{"issue":"6","key":"10.1016\/j.leukres.2017.03.008_bib0325","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1537-2995.1975.15676082242.x","article-title":"Successful control of life-threatening thrombocytosis with a blood processor","volume":"15","author":"Greenberg","year":"1975","journal-title":"Transfusion"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2017.03.008_bib0330","first-page":"24","article-title":"Plateletpheresis with the new COBE Spectra","volume":"18","author":"Kretschmer","year":"1991","journal-title":"Infusionstherapie"},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0335","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jca.2920060106","article-title":"Plateletpheresis with the COBE spectra single needle access option","volume":"6","author":"McLeod","year":"1991","journal-title":"J. Clin. Apher."},{"issue":"5","key":"10.1016\/j.leukres.2017.03.008_bib0340","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood.V50.5.927.927","article-title":"Plateletpheresis in the management of thrombocytosis","volume":"50","author":"Taft","year":"1977","journal-title":"Blood"},{"issue":"Suppl. 5","key":"10.1016\/j.leukres.2017.03.008_bib0345","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/039139889301605s40","article-title":"Therapeutic thrombocytapheresis: a review of 132 patients","volume":"16","author":"Adami","year":"1993","journal-title":"Int. J. Artif. Organs"},{"issue":"2","key":"10.1016\/j.leukres.2017.03.008_bib0350","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.transci.2013.06.003","article-title":"Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India","volume":"49","author":"Patidar","year":"2013","journal-title":"Transfus. Apher. Sci."},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0355","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1423-0410.1999.7710024.x","article-title":"Adverse events in platelet apheresis donors: a multivariate analysis in a hospital-based program","volume":"77","author":"Despotis","year":"1999","journal-title":"Vox Sang."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0360","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bjhh.2014.03.008","article-title":"Risk factors associated with the occurrence of adverse events in plateletpheresis donation","volume":"36","author":"Barbosa","year":"2014","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0365","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00277-016-2826-4","article-title":"Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey","volume":"96","author":"Koren-Michowitz","year":"2017","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2017.03.008_bib0370","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/0973-6247.150961","article-title":"Therapeutic platelet reduction: use in postsplenectomy thrombocytosis","volume":"9","author":"Gita Negi","year":"2015","journal-title":"Asian J. Transfus. Sci."},{"issue":"2","key":"10.1016\/j.leukres.2017.03.008_bib0375","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<130::AID-AJH8>3.0.CO;2-Z","article-title":"Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases","volume":"60","author":"Garcia-Manero","year":"1999","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2017.03.008_bib0380","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jhsa.2007.05.010","article-title":"Digital ischemia due to essential thrombocythemia: a case report","volume":"32","author":"Papadonikolakis","year":"2007","journal-title":"J. Hand Surg. Am."},{"issue":"3","key":"10.1016\/j.leukres.2017.03.008_bib0385","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8652(199711)56:3<168::AID-AJH6>3.0.CO;2-W","article-title":"Thrombotic complications in essential thrombocythemia with relatively low platelet counts","volume":"56","author":"Regev","year":"1997","journal-title":"Am. J. Hematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261730084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261730084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T07:04:39Z","timestamp":1601795079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521261730084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":77,"alternative-id":["S014521261730084X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.03.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}